المؤلفون: Gregory P. Arutyunov, Yuri M. Lopatin, Aleksandr S. Ametov, Fail T. Ageev, Mikhail B. Antsiferov, Svetlana V. Villevalde, Nadezhda G. Vinogradova, Gagik R. Galstyan, Albert S. Galyavich, Sergey R. Gilyarevskiy, Maria G. Glezer, Igor V. Zhirov, Mikhail V. Ilyin, Anastasiya Iu. Lebedeva, Sergey M. Nedogoda, Vladimir V. Salukhov, Ekaterina I. Tarlovskaya, Sergey N. Tereshchenko, Igor V. Fomin, Iurii Sh. Khalimov, Niaz R. Khasanov, Dmitriy V. Cherkashin, Sergey S. Yakushin

المصدر: Терапевтический архив, Vol 93, Iss 12, Pp 1491-1497 (2021)

مصطلحات موضوعية: empagliflozin, chronic heart failure, hospitalization, decompensation of chronic heart failure, cardiovascular mortality, chronic kidney disease, emperor-preserved trial, emperor-reduced trial, empa-reg outcome trial, clinical inertia, Medicine

وصف الملف: electronic resource

Relation: https://ter-arkhiv.ru/0040-3660/article/viewFile/96474/70727; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342

URL الوصول: https://doaj.org/article/cb0d25caa8e542fa8a22693834a280ca

المؤلفون: Vallon, Volker, Thomson, Scott C

المصدر: Diabetologia. 60(2)

مصطلحات موضوعية: Kidney Disease, Diabetes, Nutrition, Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Metabolic and endocrine, Renal and urogenital, Good Health and Well Being, Diabetes Mellitus, Type 2, Glucose, Humans, Hyperglycemia, Insulin Resistance, Kidney, Phlorhizin, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2 Inhibitors, Body weight, Cardiovascular outcome, Chronic kidney disease, Diabetic nephropathy, EMPA-REG OUTCOME trial, Glomerular hyperfiltration, Gluconeogenesis, Hypertension, Renal glucose reabsorption, Review, Sodiumglucose cotransport, Sodium glucose cotransport, Clinical Sciences, Paediatrics and Reproductive Medicine, Public Health and Health Services, Endocrinology & Metabolism

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/7k59g99c

المؤلفون: S. V. Villevalde, A. S. Galyavich, N. G. Vinogradova, E. N. Volodina, I. R. Gaisin, S. R. Gilyarevsky, L. V. Grekhova, Yu. A. Guryanova, P. S. Guseva, D. V. Duplyakov, A. V. Ezhov, N. E. Zakirova, Yu. V. Zolotova, A. V. Isakov, S. V. Kanysheva, Z. F. Kim, V. P. Kuzmin, S. S. Markiyanova, S. A. Pomosov, A. P. Rebrov, E. I. Tarlovskaya, S. N. Tolstov, I. V. Fomin, N. R. Khasanov, A. M. Shutov

المصدر: Российский кардиологический журнал, Vol 26, Iss 2S (2021)

مصطلحات موضوعية: empagliflozin, heart failure, cardiovascular mortality, chronic kidney disease, emperor-reduced trial, empa-reg outcome trial, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://russjcardiol.elpub.ru/jour/article/view/4562; https://doaj.org/toc/1560-4071; https://doaj.org/toc/2618-7620

URL الوصول: https://doaj.org/article/280165940e9842ad9ebdbae9d1c6f1fa

المؤلفون: Editorial team Diabetes Mellitus

المصدر: Сахарный диабет, Vol 19, Iss 2, Pp 182-185 (2016)

مصطلحات موضوعية: empaglflozin, type 2 diabetes mellitus, cardiovascular disease, mortality, empa-reg outcome trial, Nutritional diseases. Deficiency diseases, RC620-627

وصف الملف: electronic resource

Relation: https://www.dia-endojournals.ru/jour/article/view/7968; https://doaj.org/toc/2072-0351; https://doaj.org/toc/2072-0378

URL الوصول: https://doaj.org/article/5f7ca36e59854d25a5d206eef64bffb3

المؤلفون: M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov

المصدر: Рациональная фармакотерапия в кардиологии, Vol 12, Iss 2, Pp 186-190 (2016)

مصطلحات موضوعية: empagliflozin, type 2 diabetes mellitus, cardiovascular morbidity and mortality, empa-reg outcome trial, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://www.rpcardio.online/jour/article/view/1237; https://doaj.org/toc/1819-6446; https://doaj.org/toc/2225-3653

URL الوصول: https://doaj.org/article/d608ec07d496465b915f7574e313a79b

المؤلفون: Ningning Wan, Asadur Rahman, Hirofumi Hitomi, Akira Nishiyama

المصدر: Frontiers in Endocrinology, Vol 9 (2018)

مصطلحات موضوعية: sodium-glucose cotransporter 2 (SGLT2) inhibitor, EMPA-REG OUTCOME trial, CANVAS program, blood pressure, heart rate, sympathetic nervous activity, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fendo.2018.00421/full; https://doaj.org/toc/1664-2392

URL الوصول: https://doaj.org/article/6b08271ad5684dbca1ad570a5e6b81ab

المؤلفون: Anna Garmpi, Paraskevi Farmaki, Vasileios Antoniou, Lourdes Victoria Quiles-Sánchez, Eleni Memi, Konstantina Kyre, Georgios Kyriakos, Spyridon Savvanis

المصدر: Current Cardiology Reviews

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, diabetes type 2 mellitus, CVD-REAL study, T2DM, Class effect, Outcome (game theory), Article, cardiovascular events, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, In patient, Hypoglycemic drugs, Sodium-Glucose Transporter 2 Inhibitors, EMPA-REG OUTCOME trial, business.industry, class effect, General Medicine, medicine.disease, 030104 developmental biology, Drug class, Diabetes Mellitus, Type 2, Cardiovascular Diseases, 030220 oncology & carcinogenesis, Cardiology and Cardiovascular Medicine, business, Cardiovascular outcomes, SGLT2 inhibitors

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5f9faf15c29e82882b9300b0d3b891
https://doi.org/10.2174/1573403x15666190730094215

المؤلفون: ШЕСТАКОВА МАРИНА ВЛАДИМИРОВНА, БОЙЦОВ СЕРГЕЙ АНАТОЛЬЕВИЧ, ДРАПКИНА ОКСАНА МИХАЙЛОВНА, ДЕМИДОВА ТАТЬЯНА ЮЛЬЕВНА, ДРЕКСЕЛЬ ХАЙНЦ, АНЦИФЕРОВ МИХАИЛ БОРИСОВИЧ, ПЕТУНИНА НИНА АЛЕКСАНДРОВНА, ЧЕРНИКОВА НАТАЛЬЯ АЛЬБЕРТОВНА, КАЛАШНИКОВ ВИКТОР ЮРЬЕВИЧ, БАРДЫМОВА ТАТЬЯНА ПРОКОПЬЕВНА, ПРОТАСОВ КОНСТАНТИН ВИКТОРОВИЧ, БАБЕНКО АЛИНА ЮРЬЕВНА, РУЯТКИНА ЛЮДМИЛА АЛЕКСАНДРОВНА, КЛИМОНТОВ ВАДИМ ВАЛЕРЬЕВИЧ, САЛУХОВ ВЛАДИМИР ВЛАДИМИРОВИЧ, ФАДЕЕВ ВАЛЕНТИН ВИКТОРОВИЧ, КАРПОВ ЮРИЙ АЛЕКСАНДРОВИЧ

مصطلحات موضوعية: ЭМПАГЛИФЛОЗИН,САХАРНЫЙ ДИАБЕТ 2 ТИПА,СЕРДЕЧНО-СОСУДИСТАЯ ЗАБОЛЕВАЕМОСТЬ И СМЕРТНОСТЬ,ИССЛЕДОВАНИЕ EMPA-REG OUTCOME,EMPAGLIFLOZIN,TYPE 2 DIABETES MELLITUS,CARDIOVASCULAR MORBIDITY AND MORTALITY,EMPA-REG OUTCOME TRIAL

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/rezolyutsiya-promezhutochnogo-soveschaniya-ekspertnogo-soveta-po-rezultatam-issledovaniya-empa-reg-outcome
http://cyberleninka.ru/article_covers/16673017.png

المؤلفون: RIDDERSTRÅLE, MARTIN, TOURAL, ELVIRA, FITCHETT, DAVID, GILJANOVIC KÎS, SANJA, WOERLE, HANS JURGEN, MATTHEUS, MICHAELA, ZINMAN, BERNARD, INZUCCHI, SILVIO E.

مصطلحات موضوعية: EMPA-REG Outcome trial, empagliflozin, CV death, age-subgroups

URL الوصول: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::1c5ea76751fafbe94a156d21d619240f
https://www.bib.irb.hr/841667

المصدر: Рациональная фармакотерапия в кардиологии.

مصطلحات موضوعية: ЭМПАГЛИФЛОЗИН,САХАРНЫЙ ДИАБЕТ 2 ТИПА,СЕРДЕЧНО-СОСУДИСТАЯ ЗАБОЛЕВАЕМОСТЬ И СМЕРТНОСТЬ,ИССЛЕДОВАНИЕ EMPA-REG OUTCOME,EMPAGLIFLOZIN,TYPE 2 DIABETES MELLITUS,CARDIOVASCULAR MORBIDITY AND MORTALITY,EMPA-REG OUTCOME TRIAL

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2806::5ceda75c46bf88bbc2489d45a8d6d40d
http://cyberleninka.ru/article/n/rezolyutsiya-promezhutochnogo-soveschaniya-ekspertnogo-soveta-po-rezultatam-issledovaniya-empa-reg-outcome